Cargando…
A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size depen...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516882/ https://www.ncbi.nlm.nih.gov/pubmed/26283961 http://dx.doi.org/10.3389/fphar.2015.00151 |
_version_ | 1782383113657122816 |
---|---|
author | Barrett, Jeffrey S. Hirankarn, Sarapee Holford, Nick Hammer, Gregory B. Drover, David R. Cohane, Carol A. Anderson, Brian Dombrowski, Erin Reece, Tammy Zajicek, Anne Schulman, Scott R. |
author_facet | Barrett, Jeffrey S. Hirankarn, Sarapee Holford, Nick Hammer, Gregory B. Drover, David R. Cohane, Carol A. Anderson, Brian Dombrowski, Erin Reece, Tammy Zajicek, Anne Schulman, Scott R. |
author_sort | Barrett, Jeffrey S. |
collection | PubMed |
description | Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size dependencies; and determine vulnerable populations or patient subtypes that may elicit dosing modifications. A multi-center, randomized, double-blinded, parallel-group, dose-ranging, effect-controlled study, followed by an open-label dose titration of an intravenous infusion of SNP was undertaken in 203 pediatric subjects, who required deliberate hypotension or controlled normotension during anesthesia. A total of 3464 MAP measurements collected from 202 patients during the study's blinded phase, including baseline measurements up to 6 min prior to the blinded were available for analysis. A population K-PD model was developed with a one-compartment model assumed for SNP. Size differences in CL and V of the effect compartment were described using theory-based allometry. An inhibitory sigmoidal E(max) model was used to describe the effect of SNP. A power function of age was used to describe age-related differences in baseline MAP. A mixture model of two groups with low and high EC50 was used to explain variability in MAP response. Change in MAP was characterized by a linear disease progression slope during the blinded phase. In the final population model, CL and V increased with weight, and baseline MAP increased with age. The effect compartment half-life of SNP was 13.4 min. The infusion rate producing 50% of E(max) (ER50) at steady state for high EC50, was 0.34 μg/kg/min and for low EC50 0.103 μg/kg/min. The K-PD model well-describes initial dosing of SNP under controlled circumstances; model-based dosing guidance agrees with current practice. An initial titration strategy supported via algorithm-based feedback should improve maintenance of target MAP. |
format | Online Article Text |
id | pubmed-4516882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45168822015-08-17 A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children Barrett, Jeffrey S. Hirankarn, Sarapee Holford, Nick Hammer, Gregory B. Drover, David R. Cohane, Carol A. Anderson, Brian Dombrowski, Erin Reece, Tammy Zajicek, Anne Schulman, Scott R. Front Pharmacol Pharmacology Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size dependencies; and determine vulnerable populations or patient subtypes that may elicit dosing modifications. A multi-center, randomized, double-blinded, parallel-group, dose-ranging, effect-controlled study, followed by an open-label dose titration of an intravenous infusion of SNP was undertaken in 203 pediatric subjects, who required deliberate hypotension or controlled normotension during anesthesia. A total of 3464 MAP measurements collected from 202 patients during the study's blinded phase, including baseline measurements up to 6 min prior to the blinded were available for analysis. A population K-PD model was developed with a one-compartment model assumed for SNP. Size differences in CL and V of the effect compartment were described using theory-based allometry. An inhibitory sigmoidal E(max) model was used to describe the effect of SNP. A power function of age was used to describe age-related differences in baseline MAP. A mixture model of two groups with low and high EC50 was used to explain variability in MAP response. Change in MAP was characterized by a linear disease progression slope during the blinded phase. In the final population model, CL and V increased with weight, and baseline MAP increased with age. The effect compartment half-life of SNP was 13.4 min. The infusion rate producing 50% of E(max) (ER50) at steady state for high EC50, was 0.34 μg/kg/min and for low EC50 0.103 μg/kg/min. The K-PD model well-describes initial dosing of SNP under controlled circumstances; model-based dosing guidance agrees with current practice. An initial titration strategy supported via algorithm-based feedback should improve maintenance of target MAP. Frontiers Media S.A. 2015-07-28 /pmc/articles/PMC4516882/ /pubmed/26283961 http://dx.doi.org/10.3389/fphar.2015.00151 Text en Copyright © 2015 Barrett, Hirankarn, Holford, Hammer, Drover, Cohane, Anderson, Dombrowsky, Reece, Zajicek and Schulman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Barrett, Jeffrey S. Hirankarn, Sarapee Holford, Nick Hammer, Gregory B. Drover, David R. Cohane, Carol A. Anderson, Brian Dombrowski, Erin Reece, Tammy Zajicek, Anne Schulman, Scott R. A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
title | A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
title_full | A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
title_fullStr | A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
title_full_unstemmed | A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
title_short | A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
title_sort | hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516882/ https://www.ncbi.nlm.nih.gov/pubmed/26283961 http://dx.doi.org/10.3389/fphar.2015.00151 |
work_keys_str_mv | AT barrettjeffreys ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT hirankarnsarapee ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT holfordnick ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT hammergregoryb ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT droverdavidr ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT cohanecarola ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT andersonbrian ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT dombrowskierin ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT reecetammy ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT zajicekanne ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT schulmanscottr ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT barrettjeffreys hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT hirankarnsarapee hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT holfordnick hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT hammergregoryb hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT droverdavidr hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT cohanecarola hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT andersonbrian hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT dombrowskierin hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT reecetammy hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT zajicekanne hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren AT schulmanscottr hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren |